13828911000001100: Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd) (product)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Actual medicinal product\Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd)
• \UK product\Virtual medicinal product\Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet\Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd)
• \UK product\Virtual therapeutic moiety\Co-phenotrope\Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet\Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing acetylcholine receptor antagonist\Product containing muscarinic receptor antagonist\Product containing atropine\Product containing atropine and diphenoxylate\Product containing only atropine and diphenoxylate (medicinal product)\Product containing only atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet\Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing acetylcholine receptor antagonist\Product containing muscarinic receptor antagonist\Product containing atropine\Product containing atropine and diphenoxylate\Product containing atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing only atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet\Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing acetylcholine receptor antagonist\Product containing muscarinic receptor antagonist\Product containing atropine\Product containing atropine in oral dose form (medicinal product form)\Product containing atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing only atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet\Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing atropine\Product containing atropine and diphenoxylate\Product containing only atropine and diphenoxylate (medicinal product)\Product containing only atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet\Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing atropine\Product containing atropine and diphenoxylate\Product containing atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing only atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet\Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing atropine\Product containing atropine in oral dose form (medicinal product form)\Product containing atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing only atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet\Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing diphenoxylate\Co-phenotrope\Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet\Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing diphenoxylate\Product containing atropine and diphenoxylate\Product containing only atropine and diphenoxylate (medicinal product)\Product containing only atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet\Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing diphenoxylate\Product containing atropine and diphenoxylate\Product containing atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing only atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet\Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing atropine in oral dose form (medicinal product form)\Product containing atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing only atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet\Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd)
• \Medicinal product\Product containing autonomic agent\Product containing acetylcholine receptor antagonist\Product containing muscarinic receptor antagonist\Product containing atropine\Product containing atropine and diphenoxylate\Product containing only atropine and diphenoxylate (medicinal product)\Product containing only atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet\Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd)
• \Medicinal product\Product containing autonomic agent\Product containing acetylcholine receptor antagonist\Product containing muscarinic receptor antagonist\Product containing atropine\Product containing atropine and diphenoxylate\Product containing atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing only atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet\Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd)
• \Medicinal product\Product containing autonomic agent\Product containing acetylcholine receptor antagonist\Product containing muscarinic receptor antagonist\Product containing atropine\Product containing atropine in oral dose form (medicinal product form)\Product containing atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing only atropine and diphenoxylate in oral dose form (medicinal product form)\Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet\Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
49649401000001113	Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
111537801000001110	Co-phenotrope 2.5mg/0.025mg tablets (Advanz Pharma)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module

Expanded Value Set

This concept is not in any reference sets

Back to Start